A cost analysis of inherited colorectal cancer care in Varese Province

[1]  Alan Barkun,et al.  American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome. , 2015, Gastroenterology.

[2]  A. Barkun,et al.  American Gastroenterological Association Technical Review on the Diagnosis and Management of Lynch Syndrome. , 2015, Gastroenterology.

[3]  I. Frayling,et al.  A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome. , 2014, Health technology assessment.

[4]  E. Stoffel,et al.  Familial colorectal cancer, beyond Lynch syndrome. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  W. Chow,et al.  Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary non-polyposis colorectal cancer in Singapore , 2012, Familial Cancer.

[6]  C. Boland,et al.  Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population , 2010, Cancer Prevention Research.

[7]  H T Lynch,et al.  Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications , 2009, Clinical genetics.

[8]  M. Bell,et al.  Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques. , 2008, Gynecologic oncology.

[9]  G. Capellá,et al.  Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) , 2007, Journal of Medical Genetics.

[10]  T. Ruers,et al.  Cost effectiveness of a new strategy to identify HNPCC patients , 2004, Gut.

[11]  L. Albarello,et al.  Low Incidence of Hereditary Nonpolyposis Colorectal Cancer Syndrome in a Selected Area of the Lombardy Cancer Registry , 2000, Tumori.

[12]  L. Aaltonen,et al.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.

[13]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[14]  Deborah Schrag,et al.  Benefits of Colonoscopic Surveillance and Prophylactic Colectomy in Patients with Hereditary Nonpolyposis Colorectal Cancer Mutations , 1998, Annals of Internal Medicine.

[15]  J. Chang-Claude,et al.  Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. , 1998, European journal of cancer.

[16]  C. Boland,et al.  A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.

[17]  H. Thomas.  Familial colorectal cancer. , 1993, BMJ.

[18]  T. Smyrk,et al.  Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I. , 1991, Cancer genetics and cytogenetics.

[19]  R. Kaplan,et al.  Measure Costs Right: Make the Right Decisions , 1988 .

[20]  C. Masseria.  Colorectal cancer in Italy: a review of current national and regional practice on screening and treatment , 2009, The European Journal of Health Economics.

[21]  Miolo Vitali Paola,et al.  Sperimentazione dell’Activity Based Management nella sanità pubblica: l’esperienza dell’Azienda USL 3 di Pistoia , 2004 .

[22]  Suneel Udpa,et al.  Activity-Based Costing for Hospitals , 1996, Health care management review.